Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era

Vaccine

Volumn 21, Issue 11-12, 2003, Pages 1094-1098

  Trotter, Caroline ^a   Borrow, Ray ^b   Andrews, Nick ^a   Miller, Elizabeth ^a  

^a Immunisation Division   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

Antibodies; Meningococcal infections; Seroepidemiology

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; MATERNAL ANTIBODY; MENINGOCOCCUS ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENCE; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; CHILD; CONTROLLED STUDY; CROSS REACTION; HUMAN; INCIDENCE; INFANCY; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SEROPREVALENCE; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CARRIER STATE; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SEROTYPING; WALES;

EID: 0037424112     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00630-8     Document Type: Article

References (17)

1. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1969;1307-1326.
2. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1969;1327-1348.
3. Fairley C.K., Begg N., Borrow R., Fox A.J., Jones D.M., Cartwright K. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and imunogenicity in UK infants. J. Infect Dis. 174:1996;1360-1363.
4. Richmond P., Borrow R., Miller E., Clark S., Sadler F., Fox A.et al. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect Dis. 179(6):1999;1569-1572.
5. Griffiss J.M., Goroff D.K. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J. Immunol. 130:1983;2882-2885.
6. Borrow R., Andrews N., Goldblatt D., Miller E. Serological basis for the use of meningococcal serogroup C conjugate vaccines in the United Kingdom: re-evaluation of correlates of protection. Infect Immun. 69:2001;1568-1573.
7. Santos G.F., Deck R.R., Donnelly J., Blackwelder W., Granoff D.M. Importance of complement source in measuring meningococcal bactericidal titers. Clin. Diagn. Lab. Immunol. 8:2001;616-623.
8. Osborne K., Gay N.J., Hesketh L., Morgan-Capner P., Miller E. Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int. J. Epidemiol. 29:2000;362-368.
9. Maslanka S.E., Gheesling L.L., Libutti D.E., Donaldson K.B.J., Harakeh H.S., Dykes J.K.et al. Standardisation and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:1997;156-167.
10. Cartwright K.A., Stuart J.M., Jones D.M., Noah N.D. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol. Infect. 99(3):1987;591-601.
11. Fernandez S., Arreaza L., Santiago I., Malvar A., Berron S., Vazquez J.A. Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol. Infect. 123:1999;349-357.
12. Jones G.R., Wiliams J.N., Christodoulides M., Jolley K., Heckels J.E. Lack of immunity in university students before an outbreak of serogroup C meningococcal infection. J. Infect. Dis. 181:2000;1172-1175.
13. Maiden M.C.J., Stuart J.M. On behalf of the UK Meningococcal Carriage Group. Carriage of serogroup C meningococci one year after meningococcal C conjugate polysaccharide vaccination. Lancet. 359:2002;1829-1830.
14. Gold R., Goldschneider I., Lepow M.L., Draper T.F., Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J. Infect. Dis. 137(2):1978;112-121.
15. Glode M.P., Robbins J.B., Liu T.Y., Gotschlich E.C., Orskov I., Orskov F. Cross antigenicity and immunogenicity between capsular polysaccharides of Group C Neisseria meningitidis and of Escherichia coli K92. J. Infect. Dis. 135(1):1977;94-102.
16. Ramsay M.E., Andrews N., Kaczmarksi E.B., Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet. 357:2001;195-196.
17. Andrews N, Borrow R, Miller E. Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine Using Efficacy Estimates from Post-licensure Surveillance in England (submitted for publication).